ETFs Vcanbio Cell & Gene Engineering Corp., Ltd
Aktien
A0M3LR
CNE000000545
600645
Medizinische Versorgung
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
16.31 CNY | +1.30% | +1.94% | -19.54% |
ETFs investiert in Vcanbio Cell & Gene Engineering Corp., Ltd
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,00% | 32 M€ | +4.18% | - |
% 1. Jan. | Kap. | |
---|---|---|
-19.54% | 1.02 Mrd. | |
-10.83% | 11.24 Mrd. | |
-15.14% | 7.29 Mrd. | |
+29.03% | 5.57 Mrd. | |
+0.04% | 5.31 Mrd. | |
-19.93% | 3.68 Mrd. | |
+7.75% | 2.58 Mrd. | |
-66.78% | 2.33 Mrd. | |
-11.20% | 2.23 Mrd. | |
+25.24% | 2.21 Mrd. |
- Börse
- Aktien
- A0M3LR Aktie
- ETFs Vcanbio Cell & Gene Engineering Corp., Ltd